Dr Benjamin Fiebiger | Senior Scientist, Lead Immunologist
Siolta Therapeutics

Dr Benjamin Fiebiger, Senior Scientist, Lead Immunologist, Siolta Therapeutics

2004 – 2006 B.S.
University of Hohenheim (Stuttgart), Germany

2006 – 2009 M.S.
Ludwig Maximilians University, Munich, Germany

2009 – 2013 PhD
Helmholtz Zentrum Munich, Germany
• Characterization of mechanisms of MHC class I antigen processing
and presentation

2013 – 2016 Postdoctoral Fellow
The Rockefeller University, New York City, USA
• Investigation of the role of sialylation and fucosylation in the
afferent and efferent arm of a humoral immune response
• Development of a novel immunomodulatory antibody for the
treatment of antibody- and T cell-mediated autoimmune diseases

2017 – present Senior Scientist
Siolta Therapeutics, San Francisco, USA
• Development of a live biotherapeutic product to treat allergy and
• Characterization of the immunomodulatory potential and the
mechanism of action of commensal bacteria associated with
protection from inflammatory diseases


DC Co-conference Day 2 April 4 @ 4:40

A rationally designed therapeutic consortium reshapes the gut microbiota and induces peripheral immune tolerance to protect from allergic asthma

back to speakers